Akèy › Ensifizyans kadyak › Alabama
Etid klinik pou Ensifizyans kadyak nan Alabama
23 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan Alabama.
Vil nan Alabama
Tèks ofisyèl etid la (Anglè)
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Univ of Alabama Birmingham, Birmingham
Ap rekriteFaz 2
Laj 40 a 84 · Tout sèks · Mizajou Sep 30, 2026 · NCT06979362A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Fairhope
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Advanced Cardiovascular, LLC, Alexander City
- University of Alabama at Birmingham, Birmingham
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT06736574Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
- Cardiology Associates of Mobile, Mobile
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07232030A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Diagnostic and Medical Clinic, Mobile
- Mobile Heart Specialists, PC, Mobile
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06424288Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- University of Alabama Saint Vincent's Birmingham, Birmingham
- SEC Clinical Research, Dothan
- Eastern Shore Research Institute, Fairhope
- ak 1 plis
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Birmingham
- Research Site, Centreville
- Research Site, Fairhope
- ak 4 plis
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06677060Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Alexander City
- Research Site, Fairhope
- Research Site, Huntsville
Ap rekriteFaz 3
Laj 18 a 130 · Tout sèks · Mizajou Sep 11, 2026 · NCT06307652A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- CON-10004 Fairhope, AL Investigational Site, Fairhope
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06024746A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Birmingham, AL Investigative Site 10012, Birmingham
- Fairhope, AL Investigative Site 10004, Fairhope
- Huntsville, AL Investigative Site 10026, Huntsville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06008197Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- University of Alabama at Birmingham Hospital, Birmingham
Ap rekrite
Laj 18 a 100 · Tout sèks · Mizajou Sep 9, 2026 · NCT06310031Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- Heart Center Research, LLC, Huntsville
- Mobile Infirmary Medical Center, Mobile
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07069738A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 156, Birmingham
Ap rekriteFaz 2
Laj 30 a 84 · Tout sèks · Mizajou Aug 31, 2026 · NCT07795814AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- Eastern Shore Research Institute, LLC, Fairhope
Ap rekriteFaz 2
Laj 40 a 85 · Tout sèks · Mizajou Aug 27, 2026 · NCT06793371Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Birmingham
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 20, 2026 · NCT00271180LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, Alexander City
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Aug 19, 2026 · NCT07288398A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Advanced Cardiovascular, LLC, Alexander City
- Univ of Alabama Birmingham, Birmingham
- Eastern Shore Rsrch Inst, LLC, Fairhope
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05996328Assessment of CCM in HF With Higher Ejection Fraction
- Grandview Medical Group Research, LLC, Birmingham
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT05064709A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10004 Fairhope, AL Investigational Site, Fairhope
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT06033950Forge AHEAD: Feasibility of Yoga to Improve Cognitive Function
- Auburn University, Auburn
Ap rekrite
Laj 55 ak plis · Tout sèks · Mizajou Mar 25, 2026 · NCT07489105AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
- Eastern Shore Research Institute, Fairhope
Ap rekriteEtid obsèvasyon
Laj 22 ak plis · Tout sèks · Mizajou Mar 26, 2025 · NCT06378632Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
- Heart Center Research, LLC, Huntsville
Ap rekriteFaz 4
Laj 19 ak plis · Tout sèks · Mizajou Jan 29, 2024 · NCT06218199Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.